DEUTSCHE BANK AG\ - AMPHASTAR PHARMACEUTICALS IN ownership

AMPHASTAR PHARMACEUTICALS IN's ticker is AMPH and the CUSIP is 03209R103. A total of 241 filers reported holding AMPHASTAR PHARMACEUTICALS IN in Q2 2023. The put-call ratio across all filers is 0.69 and the average weighting 0.1%.

Quarter-by-quarter ownership
DEUTSCHE BANK AG\ ownership history of AMPHASTAR PHARMACEUTICALS IN
ValueSharesWeighting
Q3 2023$984,463
-10.1%
21,406
+12.3%
0.00%0.0%
Q2 2023$1,095,666
+1.8%
19,065
-33.5%
0.00%0.0%
Q1 2023$1,075,875
+81.6%
28,690
+35.7%
0.00%
Q4 2022$592,483
+15.0%
21,145
+15.5%
0.00%
Q3 2022$515,000
-34.6%
18,309
-19.1%
0.00%
Q2 2022$787,000
+4.5%
22,637
+7.9%
0.00%
Q1 2022$753,000
+39.2%
20,978
-9.8%
0.00%
Q4 2021$541,000
+28.8%
23,259
+5.4%
0.00%
Q3 2021$420,000
-72.5%
22,077
-70.9%
0.00%
-100.0%
Q2 2021$1,529,000
+90.2%
75,877
+72.9%
0.00%
Q1 2021$804,000
+19.6%
43,896
+31.3%
0.00%
Q4 2020$672,000
+38.3%
33,443
+29.0%
0.00%
Q3 2020$486,000
-10.7%
25,917
+7.0%
0.00%
Q2 2020$544,000
-10.7%
24,211
-41.0%
0.00%
-100.0%
Q1 2020$609,000
-7.9%
41,070
+19.5%
0.00%
Q4 2019$661,000
+4.9%
34,362
+7.8%
0.00%
Q3 2019$630,000
-51.0%
31,862
-47.8%
0.00%
-100.0%
Q2 2019$1,285,000
-47.2%
61,047
-48.9%
0.00%0.0%
Q1 2019$2,436,000
+61.1%
119,391
+56.8%
0.00%0.0%
Q4 2018$1,512,000
-65.9%
76,154
-66.9%
0.00%0.0%
Q3 2018$4,431,000
+3.1%
230,418
-18.2%
0.00%0.0%
Q2 2018$4,298,000
+24.0%
281,758
+52.4%
0.00%
-50.0%
Q1 2018$3,465,000
+63.4%
184,913
+67.6%
0.00%
+100.0%
Q4 2017$2,120,000
+4.7%
110,347
-2.7%
0.00%0.0%
Q3 2017$2,024,000
+61.4%
113,419
+61.3%
0.00%0.0%
Q2 2017$1,254,000
+124.7%
70,315
+82.4%
0.00%
Q1 2017$558,000
-14.0%
38,544
+9.3%
0.00%
-100.0%
Q4 2016$649,000
-36.4%
35,266
-34.5%
0.00%0.0%
Q3 2016$1,021,000
+249.7%
53,849
+195.8%
0.00%
Q2 2016$292,000
+269.6%
18,205
+173.9%
0.00%
Q1 2016$79,000
-30.1%
6,647
-16.7%
0.00%
Q4 2015$113,000
-64.2%
7,983
-70.6%
0.00%
Q3 2015$316,000
-90.0%
27,121
-84.9%
0.00%
-100.0%
Q2 2015$3,161,000
+337.2%
179,848
+271.6%
0.00%
Q1 2015$723,000
+188.0%
48,394
+123.0%
0.00%
Q4 2014$251,00021,705
+723400.0%
0.00%
Q3 2014$030.00%
Other shareholders
AMPHASTAR PHARMACEUTICALS IN shareholders Q2 2023
NameSharesValueWeighting ↓
Campbell & CO Investment Adviser LLC 11,961$219,0000.13%
FEDERATED HERMES, INC. 3,441,367$63,046,0000.12%
CORNERCAP INVESTMENT COUNSEL INC 54,751$1,003,0000.11%
GSA CAPITAL PARTNERS LLP 34,425$631,0000.10%
First Trust Direct Indexing L.P. 11,913$218,0000.06%
Summit Global Investments 47,546$871,0000.06%
WINTON GROUP Ltd 49,766$912,0000.05%
FULLER & THALER ASSET MANAGEMENT, INC. 397,950$7,290,0000.05%
AIGEN INVESTMENT MANAGEMENT, LP 16,077$295,0000.04%
EXCHANGE TRADED CONCEPTS, LLC 52,334$959,0000.04%
View complete list of AMPHASTAR PHARMACEUTICALS IN shareholders